Prevantics® device swab from PDI receives FDA 510k market authorization


PDI report “PDI, manufacturer of market-leading infection prevention products and solutions, announced the introduction of Prevantics® Device Swab, the only Chlorhexidine Gluconate/alcohol solution that has received market authorization from the U.S. Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use on ports and hubs.”

Click here for the full press release.

Thank you to our partners for supporting IVTEAM

Main page


Comments are closed.